In an attempt to understand the genetic predisposition to the gender-biased risk of cutaneous melanoma, a gene prioritization approach and case-control study design were used to measure melanoma associations with a group of 13 SNPs from the ER/IGF1R pathway. The gene discussed is IGF1R; the disease is melanoma.